1. |
Kang Y, Zhang ZJ, Zhao XY, et al. Total hip arthroplasty for vascular necrosis of the femoral head in patients with systemic lupus erythematosus:a midterm follow-up study of 28 hips in 24 patients[J]. Eur J Orthop Surg Traumatol, 2013, 23(1):73-79.
|
2. |
Woo MS, Kang JS, Moon KH. Outcome of total hip arthroplasty for avascular necrosis of the femoral head in systemic lupus erythematosus[J]. J Arthroplasty, 2014, 29(12):2267-2270.
|
3. |
Issa K, Naziri Q, Rasquinha VJ, et al. Outcomes of primary total hip arthroplasty in systemic lupus erythematosus with a proximally-coated cementless stem[J]. J Arthroplasty, 2013, 28(9):1663-1666.
|
4. |
Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment[J]. J Bone Jiont Surg Br, 1985, 76(1):3-9.
|
5. |
Arlet J, Mazieres B. Natural development of non-traumatic osteonecrosis of the hip[J]. Acta Orthop Belg, 1999, 65(Suppl 1):47-50.
|
6. |
Orban H, Cîrstoiu C, Adam R. Total hip arthroplasty in secondary systemic lupus erythematosus femoral head avascular necrosis[J]. Rom J Intern Med, 2007, 45(1):123-129.
|
7. |
Abu-Shakra M, Urowitz MB, Gladman DD, et al. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death[J]. J Rheumatol, 1995, 22(7):1259-1264.
|
8. |
Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort[J]. Arthritis Rheum, 1995, 38(10):1492-1499.
|
9. |
Takahashi T, De-La-Garza L, Ponce-De-Leon S, et al. Risk factors for operative morbidity in patients with systemic lupus erythematosus:an analysis of 63 surgical procedures[J]. Am Surg, 1995, 61(3):260-264.
|
10. |
Ito H, Matsuno T, Hirayama T, et al. Health-related quality of life in patients with systemic lupus erythematosus after medium to long-term follow-up of hip arthroplasty[J]. Lupus, 2007, 16(5):318-323.
|
11. |
Zangger P, Gladman DD, Urowitz MB, et al. Outcome of total hip replacement for avascular necrosis in systemic lupus erythematosus[J]. J Rheumatol, 2000, 27(4):919-923.
|
12. |
Henriques HF, Lebovic D. Defining and focusing perioperative steroid supplementation[J]. Am Surg, 1995, 61(9):809-813.
|
13. |
袁燕林, 吕厚山, 林剑浩, 等. 服用激素的类风湿关节炎患者人工全膝关节置换术[J]. 中华骨科杂志, 2003, 23(10):619-621.
|
14. |
曾春, 宋炎成, 蔡道章, 等. 系统性红斑狼疮合并股骨头坏死行全髋关节置换术的特点及其并发症的防治[J/CD]. 中华关节外科杂志:电子版, 2009, 3(4):454-458.
|
15. |
董健文, 黄冬梅, 戎利民, 等. Ⅰ期双侧全髋关节置换治疗系统性红斑狼疮合并股骨头坏死的早中期疗效[J]. 中华损伤与修复杂志:电子版, 2008, 3(6):705-711.
|
16. |
黄立羡, 练克俭, 郭林新, 等. 系统性红斑狼疮激素治疗后股骨头坏死行人工全髋关节置换术围手术期处理[J]. 临床骨科杂志, 2012, 15(6):607-609.
|
17. |
郭予立, 胡奕山, 林本丹. 合并系统性红斑狼疮的股骨头坏死患者行全髋关节置换术的疗效评估[J]. 广东医学, 2013, 34(19):2984-2986.
|
18. |
Arabmotlagh M, Rittmeister M, Hennigs T. Alendronate prevents femoral periprosthetic bone loss following tota1 hip arthroplasty:prospective randomized double-blind study[J]. J Orthop Res, 2006, 24(7):1336-l341.
|